Left ventricular assist device implantation causes platelet dysfunction and proinflammatory platelet-neutrophil...

Area of Science:

• Cardiovascular Science
• Hematology
• Biomedical Engineering

Background:

• Blood flow through left ventricular assist devices (LVADs) can activate and impair platelets.
• Platelet dysfunction contributes to coagulation issues and inflammatory damage via platelet-neutrophil conjugates (PNC).

Purpose of the Study:

• To investigate platelet activation, dysfunction, and PNC formation in patients with LVADs (HeartMate II and HeartMate 3) compared to control patients undergoing coronary artery bypass grafting (CABG) and/or aortic valve replacement (AVR).

Main Methods:

• Prospective observational cohort study.
• Flow cytometry for platelet and leukocyte analysis.
• Measurement of platelet activation markers and platelet aggregometry.

Main Results:

• LVAD patients showed reduced platelet CD42b expression compared to CABG/AVR patients.
• Platelet activation markers increased and aggregation decreased post-surgery in all groups, with more significant impairment in LVAD patients.
• Platelet-neutrophil conjugates were higher in HeartMate II patients than in HeartMate 3 patients.

Conclusions:

• LVAD implantation is linked to platelet dysfunction and pro-inflammatory platelet-leukocyte interactions.
• The newer generation HeartMate 3 LVAD demonstrates less pronounced platelet activation compared to the HeartMate II.
• Further research into device-specific features could optimize LVAD therapy by minimizing platelet activation.